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Mitochondrial carriers transport nucleotides, co-factors and metabolic intermediates across the inner mitochondrial membrane permeability
barrier. They belong to a family of transporters unique to eukaryotes and they differ in structure and transport mechanism from other secondary
transporters. The main structural fold consists of a barrel of six transmembrane α-helices closed at the matrix side by a salt-bridge network at the
bottom of the cavity. The significant sequence conservation in the mitochondrial carrier family suggests that specific recognition of substrates is
coupled to a common mechanism of transport. We have identified a common substrate binding site comprising residues that are highly conserved
and, as demonstrated by mutagenesis, are essential for function. The binding site explains substrate selectivity, ion coupling and the effects of the
membrane potential on transport. The main contact points in the site are related by threefold symmetry like the common structural fold. The
substrate is bound at the midpoint of the membrane and may function as a pivot point for the movements of the transmembrane α-helices as the
carrier changes conformation. The trigger for the translocation event is likely to be the substrate-induced perturbation of the salt bridge network at
the bottom of the cavity.
© 2006 Elsevier B.V. All rights reserved.Keywords: Mitochondrial carrier; Substrate binding; Transporter; Bioinformatics; Structure1. Introduction
Members of the mitochondrial carrier family link cytosolic
and mitochondrial metabolism by facilitating transport across the
inner mitochondrial membrane. The substrates of the transporters
include nucleotides, amino acids, co-factors, carboxylic acids and
inorganic anions. These metabolites are required for processes
including oxidative phosphorylation, gluconeogenesis, the syn-
thesis and degradation of amino and fatty acids, the macromo-
lecular synthesis of proteins and nucleic acids, and thermogenesis
[1,2]. The first amino acid sequences of mitochondrial carriers
[3–7] clearly demonstrated that the carriers were structurally
related [6]. Sequence analyses indicated that the carriers have
three homologous sequence repeats of about one hundred amino
acid residues each, as was noted first in the published sequence of
the bovine ADP/ATP carrier [8]. The carriers also have a sig-
nature motif P-X-[DE]-X-X-[RK], which is highly conserved in⁎ Corresponding authors. Tel.: +44 1223 252850; fax: +44 1223 252875.
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doi:10.1016/j.bbabio.2006.03.021all members of the family and in all three repeats (PROSITE
PS50920 and PFAM PF00153).
The atomic model of the bovine mitochondrial ADP/ATP
carrier (BtAAC1) has explained these sequence features in
molecular detail [9]. The main structural fold is a bundle of six α-
helices with threefold pseudo symmetry (Fig. 1). The prolines of
the signature motif induce a sharp kink in the odd-numbered α-
helices, which close the central pore of the α-helical bundle on
the matrix side. These α-helices are held together by salt-bridges
that are formed between the charged residues of the three sig-
nature motifs, and a re-arrangement of these bonds would open
the carrier to the mitochondrial matrix side (Fig. 1) [10].
The structure also provided detailed information on how the
inhibitor carboxy-atractyloside (CATR) is bound in the open
cavity formed by the α-helical bundle [9]. The inhibitor is not an
obvious structural analogue of ADP because it is larger and does
not have the same functional groups. This means that the
nucleotide binding site has not been defined structurally.
Mutagenesis has shown that some of the amino acid residues
involved in the binding of CATR are essential for adenine nucleo-
tide transport, but these residues could be involved in any part of
Fig. 1. Threefold pseudo three-fold symmetry of the ADP/ATP carrier, the salt bridge network and the substrate binding site. Structure of the bovine ADP/ATP carrier
BtAAC1 viewed from the intermembrane space (A) and the membrane (B). The coordinates for the structure were obtained from PDB entry 1okc [9]. The odd-
numbered, even-numbered and matrix α-helices are coloured in red, blue and green, respectively. The salt bridge network at the bottom of the cavity is indicated by the
letter S and by red dotted lines between positively and negatively amino acid residues of the signature motif. Also shown is a schematic representation of the salt-bridge
network at the bottom of the cavity. An ADP molecule is bound to the proposed substrate binding site at contact points I, II, and III [11].
Fig. 2. Role of yeast mitochondrial carriers in mitochondrial and cellular metabolism. Schematic representation of the yeast mitochondrial inner membrane, showing
ATP synthase, the complexes of the respiratory chain and mitochondrial carriers. The outer mitochondrial membrane is not shown. Red arrows indicate the metabolic
pathways, which are simplified to emphasise key metabolites. Co-factors, high-energy intermediates and reducing equivalents are indicated in green. Note that the
same metabolites appear at different sites, indicating that the corresponding pathways are linked. Blue arrows show the directionality of the transport steps over the
inner mitochondrial membrane as carried out by the membrane proteins. The proposed transporters of CoA, FAD, iron and pyruvate are marked with a question mark,
because the substrate has not been confirmed by transport assays with purified and reconstituted protein. The references that describe the assignment of functions are
given in the main text. Only one isoform of the identified carriers is shown.
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Fig. 4. Models of the salt bridge network formed by the signature motifs of the yeast A
of Aac3p [28] and Ndt2p [12] are shown as tubes and are viewed from the intermemb
representations. Also shown is a schematic representation of the salt bridge network
Fig. 3. The unrooted phylogenetic tree of the mitochondrial carrier family in
Saccharomyces cerevisiae. The phylogenetic tree was calculated from ungapped
multiple protein sequence alignments of the six transmembrane α-helices using
maximum likelihood implemented in the application ProML of the PHYLIP3.6
package [61]. The JTT substitution matrix was used for the exchangeability
parameters of amino acids, with a gamma correction to allow for rate
heterogeneity [62]. The alpha parameter of the gamma distribution was varied
systematically to find an optimal value. The Aac1p and Aac3p isoforms of the
ADP/ATP carrier Aac2p are omitted as is Mrs4p, a homologue of Mrs3p. The
yeast proteins YDR470c and YHM2 were excluded from the phylogenetic
analysis.
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exclusive [9], indicating that the binding sites probably overlap.
The ADP/ATP carrier binds CATR when the substrate bind-
ing site for ADP is open to the mitochondrial intermembrane
space and the structure agrees with this notion. However, what
stage in the transport cycle has been captured? As CATR could
be binding and distorting the binding site of ADP, the structure
may not resemble the empty state of the carrier. It may also not
represent the nucleotide-binding state, because this should have
led to a conformational change to a state that is open to thematrix
side. In this review, we will describe series of steps that have led
to our hypothesis for substrate recognition and binding [11]. Our
basic approach was to correlate well-defined substrate specific-
ity [12–29] to a binding site in structural models of the carriers
based on the bovine ADP/ATP carrier [9]. The common sub-
strate binding site for mitochondrial carriers is supported by
amino acid conservation and experimental evidence.
1.1. The substrate specificity of yeast mitochondrial carriers
The characteristic sequence features of mitochondrial carriers
provide the means to search for genes that encode mitochondrial
carriers in genome sequences. The total number of mitochon-
drial carriers found in genomes correlates roughly with the
extent of the biosynthetic capability of the organism. Eukaryotic
parasites that harvest metabolites from the host cell have a small
number of carriers (1 to 9), whereas plants, which have a re-
latively large biosynthetic capability, have close to 60. The
transport properties of yeast and human mitochondrial carriers
have been well characterised [1,30]. The most successful stra-
tegy for identification of the function of carriers is based on the
over-expression of the carrier in inclusion bodies in E. coli,DP/ATP carrier Aac3p (A) and the NAD+ carrier Ndt2p (B). The structural folds
rane space. The interacting side chains of the signature motif are shown in stick
with the anomalies in the signature motif encircled by a dotted line.
Fig. 5. Superposition of CATR and ADP (A) and different conformations of
ADP in the substrate binding site (B). (A) Carbon atoms of CATR and ADP are
shown in green and in blue, respectively. Oxygen atoms, sulphur atoms and
phosphorous atoms in red, yellow and purple, respectively. (B) Representation
of the bovine ADP/ATP carrier BtAAC1 (1 OKC) [9] with ADP docked in the
substrate binding site in different conformations (from PDB entries 1g99, 1a9x,
1rfu, 1ty8, 1e3m, 1w0j,1e3m,1woj, 1nne, 1oz4, and 1m7h). Amino acid
residues involved in the binding of ADP are indicated in stick representations.
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assays [31]. Other approaches use the functional expression of
mitochondrial carriers in yeast mitochondria [24] or in the
cytoplasmic membrane of the Gram-positive bacterium Lacto-
coccus lactis [32].
The starting point for our analysis was the yeast mitochondrial
carrier proteome (Fig. 2). Out of the 35 carriers encoded by the
nuclear genome, 22 have been identified in transport assays by
using purified reconstituted protein. They are three isoforms of the
ADP/ATP carrier (Aac1p, Aac2p and Aac3p) [28,29], the aspar-
tate–glutamate carrier (Agc1p) [18], the peroxisomal adenine
nucleotide transporter (Ant1p) [21], the carnitine carrier (Crc1p)
[24], the citrate transport protein (Ctp1p) [33], the dicarboxylate
carrier (Dic1p) [34], the GDP/GTP carrier (Ggc1p) [15], two
isoforms of the phosphate carrier (Mir1p and Pic2p) [20,35], the
oxaloacetate carrier (Oac1p) [23], two isoforms of the oxodi-
carboxylate carrier (Odc1p and Odc2p) [22], the ornithine trans-
porter (Ort1p) [26], the S-adenosylmethionine (SAM) transporter
(Pet8p) [17], the Mg2+–ATP/Pi carrier (Sal1p) [14,16], the
succinate–fumarate carrier (Sfc1p) [25], the pyrimidine trans-
porter (Rim2p) [13], the thiamine pyrophosphate carrier (Tpc1p)
[19], and two isoforms of the NAD+ transporter (Ndt1p and
Ndt2p) [12]. There are four carriers for which clues for a substrate
have been obtained from genetic studies and accumulation of
compounds in mitochondria, namely the FAD carrier [36], the
CoA transporter [37], and the two isoformsMrs3p andMrs4p that
are involved in iron accumulation [38,39]. The yeast carrier
YIL006w has been proposed to be the pyruvate carrier [40], but
transport studies have shown that it is one of the two isoforms of
theNAD+ carrier [12]. Therefore, the gene for the pyruvate carrier
remains to be identified and is possibly among the nine yeast
mitochondrial carriers without assigned functions.
1.2. Classification of the yeast mitochondrial carriers by
substrate and phylogeny
The substrates that are transported by the members of the
yeast mitochondrial carrier family vary in size, functional groups
and charge. On the basis of the structure of the substrates, the
proteins were classified into three major subfamilies; (i) trans-
porters of amino acids (Agc1p, Crc1p, Ort1p and Pet8p), (ii)
carriers of keto acids (Ctp1p, Dic1p, Oac1p, Odc1p, Odc2p, and
Sfc1p), and (iii) transporters of adenine nucleotides (Aac1p,
Aac2p, Aac3p, Ant1p, Pet8p, Sal1p, Ntd1p and Ndt2p). As the
substrate S-adenosyl methionine contained both a zwitterion and
an adenine moiety, the carrier Pet8p was placed in two subfam-
ilies initially.
The phylogenetic tree of yeast mitochondrial carriers shows
four major clades, consistent with the classification based on
substrate structure (Fig. 3). One clade consists of the adenine
nucleotide transporters, the second of keto acid and phosphate
carriers and the remaining two clades contain the amino acid
carriers. The peroxisomal ATP/AMP carrier Ant1p forms a sep-
arate group from the mitochondrial carriers. Ggc1p, Mir1p and
Pic2p cluster withmembers of the keto acid transporter subfamily,
Tpc1p and Rim2p with the adenine nucleotide subfamily and
Agc1p with the keto acid rather than the amino acid carriers.1.3. Comparative models of the yeast mitochondrial carriers
In order to study substrate binding sites, comparative models
were built by using sequence alignments and the structure of the
bovine ADP/ATP carrier as a template [9]. Despite the fact that
the carriers have relatively low sequence identity, there is very
little ambiguity in the alignments because of the threefold
repeats, signature motifs and other highly conserved amino acid
residues. The transmembrane α-helices are also strongly am-
phipathic, with one face of each α-helix interacting with the
lipid bilayer and the other facing the water-filled cavity. Often,
the residues in the cavity are highly conserved compared with
those interacting with the lipid bilayer and others in the loop
regions. These properties provided additional guides for the
amino acid sequence alignments.
Residues in the signature motif P-X-[DE]-X-X-[KR] were
not absolutely conserved. Firstly, proline is replaced by serine in
YMR166c (S73), Aac1p (S138), Aac2p (S147) and Aac3p
(S136), and so its Cβ O was hydrogen-bonded to the main chain
to mimic proline (Fig. 4A). Secondly, the signature motifs of the
first repeat in Flx1p, Rim2p, YEL006w and YIL006w contain
tryptophan instead of the expected acidic residue, but they have
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cation–π interaction [41] (Fig. 4B).
1.4. The substrate binding site of keto and amino acid
transporters
Amino acid and keto acid substrates are relatively small and
often they possess the same functional groups. For example, the
2-oxoglutarate substrate of Odc1p is identical to glutamate, the
substrate of Agc1p, except for having an amino rather than a
keto group on the C2 carbon. The Ort1p substrate arginine and
Agc1p substrate glutamate are both amino acids but they differ
in the functional group of the side chain, i.e., carboxyl versus
amino. This means that the substrate binding sites of carriers
must be able to recognise all functional groups simultaneously
in order to discriminate between the various substrates. In other
words, the substrate binding site must have several residues ofFig. 6. Amino acid sequence alignment of the even numbered transmembrane α-helic
boxes above the alignment indicate the residues that face the cavity. The alignment
asterisks and by a white box around the relevant residues. The abbreviations Bt st
(Saccharomyces cerevisiae) carriers.compatible chemistry in the correct spatial geometry to bind the
substrate. The side chains in the water-filled cavity were the
most likely candidates for the interactions with the substrate.
The peptide units of the backbone are unlikely to be involved in
substrate binding, because they participate in hydrogen bonding
required for the structural integrity of the α-helices. The side
chains interacting with the lipids were not considered because
the substrates are charged and cannot bind to the protein–lipid
interface. Finally, the loops regions were excluded as they are
relatively poorly conserved and their lengths differ.
The search for the substrate-binding site in the cavity used
two major constraints based on the principles formulated above.
The first constraint was that the chemical properties of the
functional groups had to be compatible with substrate binding.
For example, carboxyl groups of the substrate could bind to
polar and positively charged, but not to apolar or negatively
charged side chains. The second constraint was that all sidees of yeast and human mitochondrial carriers grouped by substrate type. The blue
is in the ZAPPO colouring scheme. The three contact points are indicated by
and for bovine (Bos taurus), Hs for human (Homo sapiens), and Sc for yeast
Fig. 7. Overview of the substrate binding site of the oxodicarboxylate transporter with different substrates. The natural substrates of the oxodicarboxylate carrier Odc1p
[22] are docked in the binding site, i.e., 2-oxoglutarate (A), 2-aminoglutarate (B), 2-oxoadipate (C) and 2-oxopimelate (D). Contact point III that interacts with the
carboxyl group of the common functional group has been omitted.
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of all of the functional groups of the substrate. The distance
constraintwas not applied too strictly to allow for deviations in the
atomic positions in the structure of the bovine BtAAC1 structure
demonstrated by high temperature factors, for different conform-
ers of the substrate and side chains, and for potential errors in
modelling. Thus, a set of residues was excluded as a possible
binding site only if they were clearly too far apart to bind all of the
functional groups simultaneously. A search of the cavities of the
amino and keto acid transporters based on these two criteria
revealed hundreds of potential binding sites in each carrier.
The sequence conservation shows that the structures of
mitochondrial carriers are conserved. All of them have a salt
bridge network at the bottom of the cavity that must rearrange to
allow a substrate to pass. Therefore, the specific recognition of a
substrate must be coupled to a common structural mechanism of
translocation. The most logical and practical way to satisfy thisFig. 8. Binding of adenine nucleotides to the substrate binding site in the bovine ADP
depicted in stick representations. The coordinates for the structure of the ADP/ATPrequirement is by having a unique substrate binding site in a
common position. This concept provided a third constraint. All
of the possible binding sites in the amino and keto acid carriers
were examined to identify those that were in a similar position
in the structure. Since the functional groups on the amino and
keto acid moieties are very close, the complementary side
chains interacting with these functional groups had to be close
in distance also. The specific functional groups were allowed to
bind to an area in the cavity, because their positions were less
well defined as they can adopt a large number of conformations.
In all of the amino and keto acid carriers, only 56 potential
common binding sites were identified.
Among them only six different residue pairs were capable of
binding the functional groups of the amino or keto acid
moieties, i.e., residues 182/183, 182/235, 32/235, 137/235, 190/
183 and 279/235 in the equivalent positions in the bovine ADP/
ATP carrier./ATP carrier BtAAC1. The coordination of ATP (A), ADP (B) and AMP (C) are
carrier were obtained from PDB entry 1 OKC [9].
Fig. 9. Ion coupling in the aspartate/glutamate carrier and the Mg2+–ATP/Pi
carrier. The binding site for the aspartate/glutamate carrier Agc1p [18] (A) and
the Mg2+–ATP/Pi carrier Sal1p [14,16] (B). The interacting side chains and
substrates are depicted in stick representations and Mg2+ as a sphere. The
coordination of the Mg2+ ion may require the involvement of a water molecule
(small sphere).
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discriminate between keto and amino acids. Four of the six pairs
had polar residues in the positions that interacted with either the
keto or the amino group and thus they could not discriminate
between these two types of substrates, leaving 182/183 and 190/
183 as the only two possibilities. Pair 190/183 was rejected
because steric hindrance from the intervening residues pre-
vented both functional groups binding simultaneously. Thus,
182/183 was the only combination capable of binding and
discriminating keto and amino groups. There were only three
potential areas for binding the specific functional group when
the common functional group was bound to 182/183, namely in
the neighbourhood of residues 83, 118, and 194. The residues in
the area of 118 and 194 were polar and could not discriminate
between positively and negatively charged side chains required
for the discrimination between arginine and glutamate. Thus,
residues in the area of residue 83 were the only ones capable of
discriminating between different types of amino and keto acids.
1.5. The substrate binding site of adenine nucleotide
transporters
Because adenine nucleotides are substantially larger with
more functional groups and a larger number of possible con-
formations [42], it was not possible to apply the same strategy to
identify the substrate binding site of this class of transporters. A
large number of ADP and ATP binding sites in the Protein Data
Bank [43] was inspected to deduce common chemical and
physical properties of adenine nucleotide binding. Although the
database is biased towards the P-loop motif [44], the most
common nucleotide binding fold, the general consensus was
that adenine binds in a pocket flanked by hydrophobic residues
Ile, Leu, Val or Met and that phosphates bind to the positively
charged residues Arg and Lys. In the water-filled cavity of the
ADP/ATP carrier there are very few hydrophobic amino acid
residues and the diterpenoid moiety of the inhibitor CATR binds
to a hydrophobic pocket created by Y186, I183 and G182.
Superposition of CATR and ADP shows that the adenine ring
follows the contours of the diterpenoid bicyclo-cis-decalin ring
quite well (Fig. 5A). The N1 of adenine is in the position of the
diterpenoid ethylene group and the N6 in the position of the
diterpenoid hydroxyl group, placing it close to the salt bridges.
The phosphates of the substrate are close to the two carboxyl
groups of the inhibitor. The photo-activated ADP analogue 2-
azido[α-32P]adenosine diphosphate reacts with I183, support-
ing this assignment [45]. ADP molecules were docked in var-
ious conformations in the site (Fig. 5B). Y186 guides the ribose
and phosphates to three positively charged residues at the op-
posite side of the cavity to R79, K22, and R279 (Fig. 5B). Thus,
the diterpenoid moiety and the carboxylic groups of CATR
mimic ADP, which draws the inhibitor to the substrate binding
site. The glucosidic, isovaleric and sulphate groups of CATR act
as a ‘spanner in the works’ by preventing the progression to the
alternative state by binding tightly to the carrier. Thus, the
structure can be interpreted as a trapped early to intermediate
stage in the substrate import cycle, during which the substrate/
inhibitor is bound to the binding site, but with the carrier pre-vented from progressing to the state that is accessible from the
mitochondrial matrix.
Another discovery was that the residues involved in adenine
binding are in the same position as those involved in binding
the common functional groups of keto acids or amino acids.
Residue R79 involved in binding the phosphate is in the contact
point for the specific group that defines the type of keto acid or
amino acid. The third contact point at position R279 is in-
volved in binding of phosphate. There is an equivalent residue,
either Lys or Arg in the keto acid or amino acid transporters,
which does not confer specificity but it could be involved in
binding the common carboxylate groups. Strikingly, the three
contact points are related in position by threefold pseudo
symmetry, reflecting the structural fold of the carrier. The
amino acid residues involved in substrate recognition are on
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named I, II and III.
1.6. Conservation of the substrate contact points
The most striking correlation between substrate class and
conservation of amino acids is found at contact point II on H4,
where all amino acid carriers possess the motif R-[DE], all
nucleotide carriers have G-[IVLM], and all keto acid carriers R-
[QHNT] (Fig. 6). Thus, the residues at contact point II recognise
and discriminate between the different classes of substrates. The
phosphate carriers have the binding site of keto acid transporters
and they cluster together in one clade (Fig. 3). The dicarbox-
ylate carrier Dic1p transports dicarboxylates as well as phos-
phate, which would be in agreement with this notion.
The residues at contact point I discriminate between different
substrates of the same class. Carboxyl or phosphate groups bind
to [RK], amino groups to [DE], aromatic moieties stack with
[FY], and hydrophobic moieties such as acyl or hydrophobic
side chains form van der Waals interactions with [ILV]. The
residues at contact point III are usually [RK] and they bind
either carboxyl or phosphate groups. Occasionally the residues
in the odd numbered α-helices are also involved in substrate
binding, but they are always at a similar height in the proteinFig. 10. Structures of transporters of small organic molecules. The approximate bor
hydrophobic and aromatic residues. The main structural fold is depicted in cartoon re
terminus). The substrates and substrate analogues, ADP (A), tetraphenyl-phosphonium
spheres and CPK colouring. The coordinates were taken from PDB entry 1okc for BtA
LeuT [56].with respect to the membrane plane as the three contact points.
Examples are residue K22 in the bovine ADP/ATP carrier
(Fig. 8B), residue R242 in the Mg2+–ATP carrier (Fig. 9B), and
residue E105 in the S-adenosyl methionine carrier [11,17].
These additional interactions may improve substrate selectivity
and accomplish substrate charge neutralisation.
The residues involved in substrate binding are always well-
conserved in homologous carriers from different organisms with
the same function [11]. Also, residues that have been mutated are
essential for function [9,46–50]. The proposed substrate binding
site always has the correct chemistry and geometry for binding of
the substrate, but because of the potential error in modelling, the
exact conformations of the substrate and side chains cannot be
determined.
1.7. General properties of the substrate binding site
Mitochondrial carriers usually exchange structurally related
compounds, for example ADP for ATP and malate for 2-oxo-
glutarate. Often, the exchanged compounds are the start and end
product of conversions, oxidation or transamination events in
the mitochondrial matrix and the cytoplasm. In intact mito-
chondria, substrate concentration gradients and the membrane
potential ensure that carriers translocate substrates in oneders of the membrane are indicated by purple lines based on the occurrence of
presentation coloured in a gradient from blue (amino-terminus) to red (carboxy-
(TPP) (B), and thiodigalactoside (TDG) (C) and leucine (Leu) (D), are shown in
AC1 [9], from 2f2m for EmrE [55], from 1pv7 for LacY [54] and from 2a65 for
Fig. 11. The substrate binding site of the ornithine transporter Ort1p (A) and the
ADP/ATP carrier BtAAC1 (B). Helices 1 and 6 and contact point III have been
removed. The residues of the signature motif involved in the salt bridge network
at the bottom of the cavity are depicted in yellow sticks. The residues of contact
points I and II that are interacting with the substrate are shown in blue. The
dotted circle indicates the close proximity of the NH1 or NH2 of the guanidino
(A) and the N6 of adenine (B) to the negatively charged residue of the signature
motif in the second repeat. The binding site of Ort1p is shown, but arginine is
present in all amino acid and keto acid transporters, except ORNT2, which has a
glutamine.
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in vitro. Therefore, either of the exchangeable substrates must
be able to bind to the cytoplasmic state of the carrier as
represented by the structure of the bovine ADP/ATP carrier [9].
The proposed binding site explains this property. Firstly,
substrates that have similar functional groups and length may
bind to the same site by small conformational changes in the
substrate and interacting side chains. Secondly, the binding site
has several different ways of accommodating substrates with
similar chemical properties but of different length. For example,
the Odc1p carrier can transport a variety of 2-oxo and 2-amino
dicarboxylates (Fig. 7). H186 can interact with keto and amino
groups (Fig. 7A and B) and for the second carboxylate there are
different acceptors for different carbon chain lengths (K98, K94
and R95) (Fig. 7A, C and D). Thirdly, the part or moiety of the
molecules that differs is not involved in binding. The ADP/ATP
carrier should be able to bind all adenine nucleotides to the
proposed binding site (Fig. 8). ADP and ATP are indeed able to
bind, but in case of ATP one net negative charge remains as
there are insufficient positively charged residues in the binding
site. Thus, in the presence of a negative-inside membrane
potential the movement of ATP in the direction of the mito-
chondrial matrix may be opposed. AMP is not transported by
the ADP/ATP carrier [51], but in principle, it could bind to the
site. However, binding of AMP does not involve residues at
contact point III, which may be required as the trigger for
translocation. It is also possible that K22 and R79 cannot bind
the α-phosphate of AMP simultaneously, and so the substrate
would carry a net negative charge and translocation against the
negative-inside membrane potential would be opposed.
Transport of anions into mitochondria is opposed by the
electrochemical gradient across the inner membrane. The basic
residues of the binding site overcome the energetic barrier by
compensating for the negative charges of a substrate. The citrate
carrier, for instance, has one more positively charged residue in
the binding site than the dicarboxylate carrier, Dic1p. The
substrate NAD has two negative charges on the phosphates and
one positive charge on the nicotinamide ring, producing a net
negative charge of one. FAD has two phosphates and a net
negative charge of two. In agreement, the NAD+ carrier has one
positively charged residue, whereas the FAD carrier has two
positively charged residues in the substrate binding site.
Another way of driving anions into the mitochondrion against
the electrochemical gradient is to couple their transport to cations,
especially to Mg2+ or protons. For instance, Agc1p exchanges
cytosolic glutamate plus a proton for aspartate from the mi-
tochondrial matrix [52]. At physiological pH, E600 at contact
point I would repel the carboxylate side chain of glutamate
(Fig. 9A). However, if E600 is protonated, the binding to K604
could occur and transport could proceed with concomitant proton
translocation. In other keto-acid carriers, such as Odc1p, Odc2p,
Sfc1p and Ctp1p, the acidic and histidine residues in the vicinity
of binding sites may fulfil a similar role. The binding site for the
Mg2+–ATP/Pi carrier Sal1p has a glutamate E318 in contact point
I, which could be involved in the coordination of Mg2+ [53].
Without Mg2+ the substrate would be negatively charged and
transport would be opposed by the membrane potential. In thecase of the ADP/ATP carrier, the equivalent residue is T83 and it
does not coordinate Mg2+. The negative charges on ADP are
neutralised by three positively charged residues in the binding
site, explaining why ADP/ATP transport has no requirement for
Mg2+ [51].
1.8. Position and threefold pseudo symmetry of the
substrate binding site
Mitochondrial carriers have threefold pseudo symmetry [9]. The
salt bridges formedbetween the signaturemotifs of the three repeats
link H1, H3 and H5 together, closing the passage for the substrate
(Fig. 1). The contact points of the substrate binding site are also
related by threefold pseudo symmetry and are present on H2, H4
and H6. The salt bridges are all in one plane close to the border of
the membrane on the matrix side, whereas the contact points for
substrate binding are all in one plane at the midpoint of the mem-
brane. The substrate is also at the midpoint of themembrane in four
other families of transporters with different folds and mechanisms;
the lactose permease LacY, a member of the major facilitator
superfamily [54], the small multidrug transporter EmrE [55], a
bacterial homologue of Na+/Cl−-dependent neurotransmitter
transporters LeuT [56] (Fig. 10) and the glutamate transporters
1246 E.R.S. Kunji, A.J. Robinson / Biochimica et Biophysica Acta 1757 (2006) 1237–1248[57] (not shown). The water-filled cavities in these transporters
allow the substrate to move to the midpoint in the membrane.
During the transport cycle, transporters need to be closed on one or
the other side of themembrane to prevent influx of protons and loss
of the membrane potential. This is most easily achieved by the
substrate being at the midpoint of the membrane, where it can
function as a pivot point for structural changes around it.
1.9. Mechanism for substrate-induced carrier opening
The bound substrate is suspended between residues on α-
helices H2, H4 and H6 at the bottom of a water-filled cavity,
immediately above the salt bridges that close the carrier to the
mitochondrial matrix (Fig. 11). The majority of the residues
interacting with the substrate are charged and form salt bridges.
Ionic interactions are stronger than hydrogen bonds and charged
groups are less well shielded by the water molecules. The
number of interactions between the substrate and the carrier are
minimal and just enough to recognise the substrate, which may
explain why the affinities for the substrates are in the micro-
molar range.
The location of the binding site suggests that substrate
binding and carrier opening are coupled. This could be achievedFig. 12. Rearrangement of the salt bridge interactions between the signature motifs b
which the cytoplasmic half of the transporter has been removed. The salt bridges are
carrier, in which the passage to the matrix is closed by inter-domain salt bridges f
introduction of a nitrogen atom, either the N6 of adenine or NH1/NH2 of the guanidin
the second repeat. A salt-bridge or hydrogen bond is formed between the substra
interactions (Panel 3). In the final stage, the substrate is no longer bound to the signatu
the transmembrane α-helices.by perturbation of the salt-bridge network through the intro-
duction of a nitrogen atom close to the Asp or Glu of the
signature motif of the second repeat. The nitrogen atom is either
the N6 atom of the adenine moiety of adenine nucleotides or the
guanidino NH1 or NH2 of arginine when it is bound to keto or
amino acid substrates. Thus, the arginine functions as an adapter
in two ways. First, the length of the arginine side chain ensures
that the smaller substrates keto and amino acids can bind to the
common binding site. In the adenine nucleotide transporters, the
equivalent residue is glycine, which creates a pocket for the
adenine ring. Second, the NH1 or NH2 of the guanidino group
is in a similar position to the N6 nitrogen of the adenine ring,
and both could trigger the rearrangement of the salt bridge
network in a similar way. In the current state, the passage of the
substrate to the matrix is prevented by inter-domain salt bridges
formed by the charged residues of the signature motif from the
three repeats (Stage 1 Fig. 12). The introduction of a nitrogen
atom close to the negatively charged residue of the second
repeat (Stage 2 Fig. 12) could lead to a rearrangement, in which
salt bridges are formed between residues of the same signature
motif (Stage 3 Fig. 12). When all three salt bridges have switched
to intra-domain interactions, the α-helices at the bottom of the
cavity are no longer bonded together and the passage to they substrate-induced perturbation. A view of the salt bridge network is shown in
yellow and are marked by the letter S. Panel 1 shows the state of the ADP/ATP
ormed by the signature motifs. Binding of the substrate (Panel 2) leads to the
o group of arginine in position 182, close to the aspartate of the signature motif in
te and Asp, leading to a rearrangement of the salt-bridges to all intra-domain
re motif and the carrier opens to the matrix side with concomitant movements of
1247E.R.S. Kunji, A.J. Robinson / Biochimica et Biophysica Acta 1757 (2006) 1237–1248mitochondrial matrix is open. At the same time, substrate binding
could pullα-helicesH2,H4 andH6 closer together to allow a better
fit of the substrate in the binding site, thereby providing energy for
the structural changes with the substrate as the pivot point. Salt
bridge rearrangement [10] and the participation of α-helix H4 in
substrate translocation and conformational rearrangement [58,59]
have been proposed previously as integral features of opening of
mitochondrial carriers. The position and role of the substrate are
consistent with the “single binding centre gated pore”model of the
ADP/ATP carrier, in which a single binding site is alternatively
accessible from the matrix and the cytosol [60], but a structure of
the carrier in the matrix-state is required to confirm this.
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